Shixi Yitang Huachuang Capital

The firm pursues a stage-agnostic venture strategy, covering early-stage seed and startup rounds, expansion and late-stage growth, and pre-IPO investments. This approach positions it as a generalist investor capable of backing companies throughout their development lifecycle in China.

No sector-specific focus has been publicly disclosed. The firm is described as a generalist venture and private equity investor without tagged concentrations in areas like AI, healthcare, or consumer technology, which are common among Chinese GPs.

Specific figures on assets under management, fund size, or team headcount are not publicly available. The firm does not maintain a website or LinkedIn presence, and no recent fund close announcements or regulatory filings naming detailed figures have been identified.

Deal sourcing mechanisms have not been disclosed. Given its Beijing headquarters and the absence of a public digital footprint, the firm likely relies on founder networks, local intermediary relationships, and direct origination within China's private company ecosystem.

No fundraising activity or fund vintage information has been publicly reported. Without a disclosed track record of formal fund closes, the firm's current deployment status and capital base remain unclear.